Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Respiratory Medicine Case Reports|December 15, 2020
Successful treatment with methyl-prednisolone pulses for the late phase of COVID-19 with respiratory failure: A single-center case seriesKentaro Tamura, Saiko Nishioka, Nobumasa Tamura, et al.
The Open Respiratory Medicine Journal|November 2, 2023
Usefulness of High-resolution Computed Tomography for Macrolide Therapy of Idiopathic BronchiectasisZenya Saito, Masahiro Yoshida, Shota Uchiyama, et al.
Infection Prevention in Practice|February 15, 2024
Predictors of in-hospital mortality in elderly unvaccinated patients during SARS-CoV-2 Alpha variants epidemicZenya Saito, Shota Uchiyama, Saiko Nishioka, et al.
Case Reports in Ophthalmological Medicine|July 30, 2021
Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung AdenocarcinomaMasaomi Kubota, Nobumasa Tamura, Takaaki Hayashi, et al.
Internal Medicine (Tokyo, Japan)|May 15, 2022
A Convenient Risk Prediction Score for COVID-19 for Determining Whether or Not Hospitalization Is Recommended: Kanagawa Admission Priority Assessment ScoreNobumasa Tamura, Shota Uchiyama, Saiko Nishioka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 26, 2020
Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinomaNobumasa Tamura, Yutaka Fujiwara, Taiki Hashimoto, et al.
Thoracic Cancer|March 27, 2019
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancerNobumasa Tamura, Hidehito Horinouchi, Katsutoshi Sekine, et al.
Respiratory Medicine Case Reports|April 15, 2021
Localized pleural metastasis without other organ metastases after nephrectomy for renal cell carcinomaZenya Saito, Kenichi Hata, Saiko Nishioka, et al.
Oxford Medical Case Reports|December 3, 2020
Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapyNobumasa Tamura, Yoshitaka Honma, Shigeki Sekine, et al.
Targeted Oncology|April 13, 2024
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)Naoya Nishioka, Hisao Imai, Masahiro Endo, et al.
Pageof 1